BCDA, PPPI eye pharma ecozones

The Bases Conversion and Development Authority (BCDA) and the Philippine Pharma Procurement Inc. are eyeing the establishment of specialized pharmaceutical economic zones in the country.

The signing of a memorandum of understanding at the BCDA office on 25 March 2026, solidified the idea of transforming the Philippines into a regional hub for pharmaceutical manufacturing and life sciences.

Collaborative study

The MoU’s aim is to undertake a comprehensive collaborative study for the development of specialized pharmaceutical economic zones.

The initiative will explore strategic business opportunities within the Clark Civil Aviation Complex (CCAC) in Pampanga and New Clark City in Tarlac.

The endeavor aims to stimulate industrial development in these areas, particularly in pharmaceutical manufacturing, medical equipment production, cold chain logistics and research and development.

The said plan is in line with the Marcos administration’s goal of accelerating ecozone development to create jobs, attract investments, expand growth in regions outside Metro Manila, and support inclusive economic progress.

Philippines’ long-standing reliance on imported medicines

According to BCDA, the partnership seeks to address the Philippines’ long-standing reliance on imported medicines by creating a dedicated ecosystem for pharmaceutical manufacturing, research and distribution.